Skip to Content

143 (Metformin hydrochloride extended-release 750 mg)

Pill imprint 143 has been identified as Metformin hydrochloride extended-release 750 mg.

Metformin is used in the treatment of polycystic ovary syndrome; diabetes, type 2; insulin resistance syndrome; female infertility and belongs to the drug class non-sulfonylureas. There is no proven risk in humans during pregnancy. Metformin 750 mg is not a controlled substance under the Controlled Substance Act (CSA).

Metformin hydrochloride extended-release 750 mg 143
Metformin hydrochloride extended-release 750 mg 143  Front
Metformin hydrochloride extended-release 750 mg 143  Back
Metformin hydrochloride extended-release 750 mg 143
Metformin hydrochloride extended-release
Imprint:
143
Strength:
750 mg
Color:
Red
Size:
19.00 mm
Shape:
Elliptical / Oval
Availability:
Prescription only
Drug Class:
Non-sulfonylureas
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Sun Pharmaceuticals
National Drug Code (NDC):
62756-0143
Inactive Ingredients:
xanthan gum
hypromellose
sodium carbonate
povidone
ferric oxide red
magnesium silicate
magnesium stearate
silicon dioxide

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide